drugset / Trial / NCT04867707
Role of Neuraminidase Activity on Endothelial Dysfunction in Type 2 Diabetes
NaSingle-groupOpen-labelTreatment
Summary
The objective is to determine if neuraminidase inhibition with zanamivir is efficacious as a therapeutic strategy to restore endothelial function in T2D patients.
Timeline
- Start
- 2021-07-14
- Primary completion
- 2024-10-18
- Completion
- 2024-10-18
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zanamivir | Small molecule | 10 mg | Inhaled |